Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Steve Arcona"'
Publikováno v:
Epilepsia Open, Vol 8, Iss 4, Pp 1556-1565 (2023)
Abstract Objective To gather real‐world evidence on antiseizure medications (ASMs) treatment patterns and related outcomes in patients with drug‐resistant focal epilepsy. Methods Medical insurance claims from the start of 2014 till the end of 201
Externí odkaz:
https://doaj.org/article/9817153df6484684ae98470e11e1a34e
Publikováno v:
Clinical Parkinsonism & Related Disorders, Vol 8, Iss , Pp 100173- (2023)
Objectives: To characterize patients with Parkinson’s disease (PD) who initiated dopamine agonist (DA) monotherapy, describe medication utilization and provider types, and estimate medication adherence and discontinuation rates. Methods: Retrospect
Externí odkaz:
https://doaj.org/article/a7403977a7264ae58b331915b5389c34
Autor:
Prakash Navaratnam, Steve Arcona, Howard S. Friedman, Matthew Leoni, Shajahan Shaik, Rahul Sasane
Publikováno v:
Clinical Parkinsonism & Related Disorders, Vol 6, Iss , Pp 100125- (2022)
Background: Parkinson’s disease (PD) management seeks to balance the benefits and harms of current medications and evolves as the disease progresses. The natural history of PD and associated patterns of treatment change were analyzed to identify un
Externí odkaz:
https://doaj.org/article/539a03f88edd44b0b1a3bfefd0050209
Publikováno v:
Clinical Parkinsonism & Related Disorders, Vol 6, Iss , Pp 100135- (2022)
Background: Medication regimens for Parkinson’s disease (PD) may change as the disease progresses, symptoms fluctuate, or medication-related adverse events occur. This study evaluated treatment trends by observation year for patients initially rece
Externí odkaz:
https://doaj.org/article/3a0368fbcaef4ac28ef53ed57042b1a4
Autor:
Nirmish Shah, Menaka Bhor, Lin Xie, Rashid Halloway, Steve Arcona, Jincy Paulose, Huseyin Yuce
Publikováno v:
Health and Quality of Life Outcomes, Vol 17, Iss 1, Pp 1-11 (2019)
Abstract Background This study aimed to evaluate sickle-cell disease (SCD) treatment patterns and economic burden among patients prescribed hydroxyurea (HU) in the US, through claims data. Methods SCD patients with pharmacy claims for HU were selecte
Externí odkaz:
https://doaj.org/article/b6e9bf0b690e420da138f662c7facdf9
Publikováno v:
Clinical Parkinsonism & Related Disorders, Vol 5, Iss , Pp 100109- (2021)
Introduction: Most Parkinson’s disease (PD) medication adherence studies have focused on patients with commercial or Medicare health insurance coverage. However, less is known regarding medication treatment patterns within the Medicaid population.
Externí odkaz:
https://doaj.org/article/bd39538828fd46d480dfcad658fb4444
Autor:
Nirmish Shah, Menaka Bhor, Lin Xie, Steve Arcona, Rashid Halloway, Jincy Paulose, Huseyin Yuce
Publikováno v:
Journal of Health Economics and Outcomes Research, Vol 6, Iss 3 (2019)
Sickle cell disease (SCD) is a life-threatening vascular disease that burdens affected persons physically. SCD related vaso-occlusive crises (VOCs) are one of the primary causes of morbidity and mortality. Our objective was to examine the epidemiolog
Externí odkaz:
https://doaj.org/article/20755d9f614c4aa981c9fcafcf2c759c
Publikováno v:
ClinicoEconomics and Outcomes Research. 15:309-319
Michelle Jerry,1 Steve Arcona,2 Donna McMorrow,1 Hana Schwartz,1 Nicole Princic,1 Rahul Sasane2 1Merative, Ann Arbor, MI, USA; 2Cerevel Therapeutics, Cambridge, MA, USACorrespondence: Michelle Jerry, Merative, 100 Phoenix Dr Ste 200, Ann Arbor, MI, 4
Autor:
Kristin Richards, Carolyn Brown, Michael Johnsrud, Steve Arcona, Rahul Sasane, Melissa Armstrong, Jeanne Feuerstein, Holly Shill, Lauren Talman, Sneha Mantri
Publikováno v:
Thursday, April 27.
Publikováno v:
Journal of Medical Economics. 23:243-251
Purpose: This study evaluated healthcare resource utilization (HCRU), and direct costs among severe aplastic anemia (SAA) patients treated with eltrombopag (EPAG) using US claims data.Methods: This...